Impacto de la terapia anti retroviral en la mortalidad de pacientes VIH (+) chilenos: estudio caso-control (MORTAR)

par Wolff R,Marcelo, Bustamante M,Claudia, Bidart H,Teresa, Dabanch P,Jeannette, Diomedi P,Alexis, Northland A,Rebeca
Publié 2000

Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential

par Fernandez C, van Halsema CL
Publié 2019

Antiangiogenic VEGF165b Expression in Human Breast MCF-7 and MCF-10A Cells Exposed to Reverse Transcriptase and Protease Inhibitors

par Adefolaju,Gbenga Anthony, Scholtz,Kathrine Elizabeth, Hosie,Margot Jill
Publié 2017

Past HIV-1 Medications and the Current Status of Combined Antiretroviral Therapy Options for HIV-1 Patients

par Matthew Weichseldorfer, Marvin Reitz, Olga S. Latinovic
Publié 2021

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance

par Seth C. Inzaule, Cissy M. Kityo, Margaret Siwale, Alani Sulaimon Akanmu, Maureen Wellington, Marleen de Jager, Prudence Ive, Kishor Mandaliya, Wendy Stevens, T. Sonia Boender, Pascale Ondoa, Kim C. E. Sigaloff, Denise Naniche, Tobias F. Rinke de Wit, Raph L. Hamers
Publié 2018

Doravirine and Its Potential in the Treatment of HIV: An Evidence-Based Review of the Emerging Data

par Rock AE, Lerner J, Badowski ME
Publié 2020

HIV-1 Protease and Reverse Transcriptase Inhibitory Activities of <i>Curcuma aeruginosa</i> Roxb. Rhizome Extracts and the Phytochemical Profile Analysis: In Vitro and In Silico Sc...

par Chanin Sillapachaiyaporn, Panthakarn Rangsinth, Sunita Nilkhet, Nuntanat Moungkote, Siriporn Chuchawankul
Publié 2021